Clinical trials recruiting for Gastrointestinal Cancer
20
Recruiting trials
25
US states with sites
5
Countries
10%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 4 |
| Texas | 4 |
| Massachusetts | 3 |
| New York | 3 |
| California | 2 |
| Colorado | 2 |
| Florida | 2 |
| New Jersey | 2 |
| Ohio | 2 |
| Arizona | 1 |
| Connecticut | 1 |
| Georgia | 1 |
Top cities
Boston, Massachusetts 3Houston, Texas 3New York, New York 3Baltimore, Maryland 2Bethesda, Maryland 2Los Angeles, California 2Atlanta, Georgia 1Aurora, Colorado 1Basking Ridge, New Jersey 1Chandler, Arizona 1
Self-screener
Recruiting trials
- A Study of GC203 TIL in Advanced Malignant Solid Tumors
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
- Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
- Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
- DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope
- Goals of Care Discussion for Patients With Advanced Lung and Gastrointestinal Cancer in the Emergency Department of a Comprehensive Cancer Center
- Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
- Improving Comprehensive Care of Cancer Patients
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
- Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity
- Ontario-wide Cancer TArgeted Nucleic Acid Evaluation
- Optimizing and Personalising Azacitidine Combination Therapy for Treating Solid Tumours QPOP and CURATE.AI
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- Stereotactic Brain-directed Radiation With or Without Aguix Gadolinium-Based Nanoparticles in Brain Metastases
- Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
- Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Related conditions
Trials recruiting for Gastrointestinal Cancer often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Breast cancer 2239Pancreatic cancer 870Colorectal cancer 1359Melanoma 487Head and neck cancer 62Genitourinary Cancer 9Colon cancer 96Sarcoma 48Rectal cancer 152
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Gastrointestinal Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.